EWA
COGT icon

EverSource Wealth Advisors’s Cogent Biosciences COGT Stock Holding History

EverSource Wealth Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.57K Sell
144
-1,467
-91% -$51.3K ﹤0.01% 3233
2026
Q1 		$62K Buy
1,611
+903
+128% +$33.3K ﹤0.01% 1741
2025
Q4 		$25.1K Buy
708
+652
+1,164% +$18.3K ﹤0.01% 2235
2025
Q3 		$804 Buy
56
+55
+5,500% +$652 ﹤0.01% 3821
2025
Q2 		$7 Sell
1
-18
-95% -$100 ﹤0.01% 4238
2025
Q1 		$114 Buy
19
+2
+12% +$16 ﹤0.01% 3811
2024
Q4 		$133 Buy
+17
New +$169 ﹤0.01% 3504

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

EverSource Wealth Advisors's COGT Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Cogent Biosciences (COGT) stake by 91% in Q2 2026, selling an estimated $51.3K and leaving 144 shares worth $5.57K. The position accounts for ﹤0.01% of the portfolio, ranked #3233.

EverSource Wealth Advisors first reported a position in COGT in Q4 2024 and has held it in 7 quarters since. The position peaked at $62K in Q1 2026. 322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • EverSource Wealth Advisors held 144 shares of Cogent Biosciences worth $5.57K as of Q2 2026.
  • EverSource Wealth Advisors sold 1,467 Cogent Biosciences shares in Q2 2026, an estimated $51.3K.
  • Cogent Biosciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3233 holding.
  • EverSource Wealth Advisors first reported a position in Cogent Biosciences in Q4 2024 and has held it in 7 quarters since.
  • EverSource Wealth Advisors's Cogent Biosciences position peaked at $62K in Q1 2026.
  • 322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.